Please login to the form below

Not currently logged in
Email:
Password:

AAA

This page shows the latest AAA news and features for those working in and with pharma, biotech and healthcare.

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

Shortly after Daiichi Sankyo filed its lawsuit, Seattle Genetics submitted an arbitration demand to the American Arbitration Association (AAA), saying it had been abiding by the agreement’s dispute resolution provisions.

Latest news

  • AAA board presses go on $3.9bn Novartis takeover AAA board presses go on $3.9bn Novartis takeover

    Novartis offer to buy the company was made in October and – after negotiations with company’s works council – AAA’s board has now given its blessing to the $41 per share ... AAA was spun out 15 years ago from Cern, the European nuclear research

  • Novartis to buy French radiopharma specialist AAA for $3.9bn Novartis to buy French radiopharma specialist AAA for $3.9bn

    Among AAA’s clinical candidates is 177Lu-NeoBOMB1, a radiopharmaceutical for prostate cancer, gastrointestinal stromal tumours (GIST) and breast cancer. ... Novartis is offering $41 in cash per AAA ordinary share and $82 per American Depositary Share,

  • AAA’s orphan drug Lutathera wins EU green light AAA’s orphan drug Lutathera wins EU green light

    The first-in-class drug treats adults with GEP-NET. Advanced Accelerator Applications’ (AAA) Lutathera (lutetium oxodotreotide) has received European approval to treat adults with unresectable or metastatic, somatostatin receptor positive

  • IPA 2013 Best of Health Awards open for entries IPA 2013 Best of Health Awards open for entries

    ÂÂÂ Last year McCann Torre Lazur was awarded Healthcare Professional 'Best of Show' for its 'Another busy day' campaign, on behalf of the hypertension drug Edarbi by Takeda.

  • Market turmoil continues

    The biggest companies in the US have been downgraded from AAA rating to AA along with the dollar and the US Government.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics